XCEL BRANDS INC (XELB)
US98400M1018 - Common Stock
Overall XELB gets a fundamental rating of 2 out of 10. We evaluated XELB against 126 industry peers in the Specialty Retail industry. XELB may be in some trouble as it scores bad on both profitability and health. XELB does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
XELB had negative earnings in the past year.
XELB had a negative operating cash flow in the past year.
XELB had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: XELB reported negative operating cash flow in multiple years.
1.2 Ratios
With a Return On Assets value of -29.37%, XELB is not doing good in the industry: 89.68% of the companies in the same industry are doing better.
XELB has a worse Return On Equity (-42.07%) than 67.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -29.37% | ||
| ROE | -42.07% | ||
| ROIC | N/A |
ROA(3y)-14.53%
ROA(5y)-11.3%
ROE(3y)-21.38%
ROE(5y)-16.55%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
XELB has a Gross Margin of 61.03%. This is amongst the best in the industry. XELB outperforms 94.44% of its industry peers.
XELB's Gross Margin has declined in the last couple of years.
XELB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 61.03% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.17%
GM growth 5Y-7.95%
2. Health
2.1 Basic Checks
XELB does not have a ROIC to compare to the WACC, probably because it is not profitable.
XELB has more shares outstanding than it did 1 year ago.
XELB has more shares outstanding than it did 5 years ago.
The debt/assets ratio for XELB is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -1.20, we must say that XELB is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -1.20, XELB is not doing good in the industry: 87.30% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.08 indicates that XELB is not too dependend on debt financing.
XELB has a better Debt to Equity ratio (0.08) than 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.2 |
ROIC/WACCN/A
WACC8.54%
2.3 Liquidity
XELB has a Current Ratio of 1.13. This is a normal value and indicates that XELB is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.13, XELB is not doing good in the industry: 74.60% of the companies in the same industry are doing better.
XELB has a Quick Ratio of 1.06. This is a normal value and indicates that XELB is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.06, XELB is in the better half of the industry, outperforming 69.05% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.13 | ||
| Quick Ratio | 1.06 |
3. Growth
3.1 Past
XELB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -411.12%.
The Revenue for XELB has decreased by -31.15% in the past year. This is quite bad
Measured over the past years, XELB shows a very negative growth in Revenue. The Revenue has been decreasing by -12.93% on average per year.
EPS 1Y (TTM)-411.12%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q25%
Revenue 1Y (TTM)-31.15%
Revenue growth 3Y-15.52%
Revenue growth 5Y-12.93%
Revenue growth Q2Q-43.81%
3.2 Future
The Earnings Per Share is expected to grow by 47.83% on average over the next years. This is a very strong growth
Based on estimates for the next years, XELB will show a quite strong growth in Revenue. The Revenue will grow by 18.26% on average per year.
EPS Next Y64.45%
EPS Next 2Y47.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-9.38%
Revenue Next 2Y18.26%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
XELB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year XELB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
XELB's earnings are expected to grow with 47.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.83%
EPS Next 3YN/A
5. Dividend
5.1 Amount
XELB does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
XCEL BRANDS INC
NASDAQ:XELB (5/7/2024, 9:43:47 AM)
0.8
+0.06 (+8.11%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap18.79M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -29.37% | ||
| ROE | -42.07% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 61.03% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.25
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.13 | ||
| Quick Ratio | 1.06 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-411.12%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y64.45%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-31.15%
Revenue growth 3Y-15.52%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y